Sangamo Therapeutics Inc (SGMO)
0.4541
-0.02
(-3.38%)
USD |
NASDAQ |
Jun 25, 16:00
0.446
-0.01
(-1.78%)
After-Hours: 20:00
Sangamo Therapeutics Revenue (Annual): 176.23M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 176.23M |
| December 31, 2022 | 111.30M |
| December 31, 2021 | 110.70M |
| December 31, 2020 | 118.19M |
| December 31, 2019 | 102.43M |
| December 31, 2018 | 84.45M |
| December 31, 2017 | 36.57M |
| December 31, 2016 | 19.39M |
| December 31, 2015 | 39.54M |
| December 31, 2014 | 45.87M |
| December 31, 2013 | 24.13M |
| December 31, 2012 | 21.66M |
| December 31, 2011 | 10.32M |
| December 31, 2010 | 20.80M |
| Date | Value |
|---|---|
| December 31, 2009 | 22.19M |
| December 31, 2008 | 16.19M |
| December 31, 2007 | 9.098M |
| December 31, 2006 | 7.885M |
| December 31, 2005 | 2.484M |
| December 31, 2004 | 1.315M |
| December 31, 2003 | 2.579M |
| December 31, 2002 | 4.343M |
| December 31, 2001 | 4.885M |
| December 31, 2000 | 3.433M |
| December 31, 1999 | 2.20M |
| December 31, 1998 | 2.038M |
| December 31, 1997 | 1.152M |
| December 31, 1996 | 0.632M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
102.43M
Minimum
2019
176.23M
Maximum
2023
123.77M
Average
111.30M
Median
2022